GEIGER JESSE J 4

What Happened Jesse J. Geiger, President of Medpace Holdings, exercised 31,707 stock options and sold the resulting 31,707 shares on March 17, 2026. The exercise reflected a per-share exercise price of $138.87 (total exercise cost $4,403,151). The shares were sold in the open market at a weighted average sale price of $455.30 per share, for total gross proceeds of approximately $14,436,197. The filing also shows the derivative (option) was disposed/cancelled in the process.

Key Details

• Transaction date: March 17, 2026. Filing date (Form 4): March 19, 2026 (timely).
• Option exercise: 31,707 shares @ $138.87 (total $4,403,151).
• Open-market sale: 31,707 shares @ weighted average $455.30 (total ~$14,436,197). Footnote reports actual sale prices ranged $451.36–$460.288; the reported sale price is a weighted average.
• Derivative entry at $0.00 reflects cancellation/settlement of the option upon exercise.
• Option vesting: the option vested in full on February 15, 2026 (footnote).
• Shares owned after the transaction: not specified in the excerpt; see the full Form 4 for post-transaction holdings.
• Transaction codes: M = option exercise, S = sale.

Context This appears to be a cashless exercise/monetization: the options were exercised and the underlying shares were sold the same day. Such transactions are commonly used to realize option value and do not, by themselves, indicate the insider's view of the company’s future performance. For full pricing breakdowns or ownership details, consult the complete SEC Form 4 filing.